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Abstract
Aim: The aim of this study was to assess the effect of different silver
nanoparticles (SN) concentrations on the matrix composition and structure of
Candida albicans and Candida glabrata biofilms.
Methods and Results: Candida biofilms were developed in 6-well microtiter
plates during 48 h. After, these biofilms were exposed to 135 or
54 lg SN ml1 for 24 h. Then, extracellular matrices were extracted from
biofilms and analysed chemically in terms of proteins, carbohydrates and DNA.
To investigate the biofilm structure, scanning electron microscopy (SEM) and
epifluorescence microscopy were used. SN interfered with the matrix
composition of Candida biofilms tested in terms of protein, carbohydrate and
DNA, except for the protein content of C. albicans biofilm. By SEM, Candida
biofilms treated with SN revealed structural differences, when compared with
the control groups. Further, SN showed a trend of agglomeration within the
biofilms. Epifluorescence microscopy images suggest that SN induced damage
on cell walls of the Candida isolates tested.
Conclusions: In general, irrespective of concentration, SN affected the matrix
composition and structure of Candida biofilms and these findings may be
related to the mechanisms of biocide action of SN.
Significance and Impact of the Study: This study reveals new insights about
the behaviour of SN when in contact with Candida biofilms. SN may
contribute to the development of therapies to prevent or control Candida
infections.
Introduction
Candida pathogenesis is associated with biofilm forma-
tion (Vediyappan et al. 2010), and Candida spp. can
colonize tissues or inert surfaces, such as oral epithelia
and dental prostheses, respectively (Kojic and Darouiche
2004; Ramage et al. 2006). An example of oral infection
caused by Candida biofilms is the Candida-associated
denture stomatitis, which is characterized by the pres-
ence of biofilm in the space between the denture base
and the mucosa (Budtz-Jorgensen 2000). Candida
albicans and Candida glabrata have been recognized as
the most prevalent microorganisms found in denture
stomatitis (Coco et al. 2008). Usually, Candida biofilms
are resistant to host defence mechanisms and to anti-
fungal drugs, representing a continuous source of infec-
tion (Baillie and Douglas 2000). One of the factors that
may be associated with antifungal resistance of Candida
biofilms is the presence of extracellular matrix (Mah
and O’Toole 2001).
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According to Flemming et al. (2007), the biofim matri-
ces or extracellular polymeric substances (EPS) ‘are bio-
polymers of microbial origin in which biofilm
microorganisms are embedded’. This matrix is composed
of a wide variety of proteins, carbohydrates and phosphate
(Baillie and Douglas 2000; Blankenship and Mitchell
2006). In addition, extracellular DNA has also been men-
tioned as a component of the biofilm matrices (Martins
et al. 2010).
The composition of extracellular material varies
depending on the growth medium, environmental condi-
tions and species (Conover et al. 2011). Al-Fattani and
Douglas (2006) reported that C. albicans biofilm matrix
consisted of carbohydrate (322% glucose), small
amounts of proteins (50%), hexosamine (33%), phos-
phate (05%) and uronic acid (01%), while the matrix
from Candida tropicalis biofilms consisted mainly of
hexosamine (274%), carbohydrates (33%, including
05% glucose), proteins (33%), phosphate (02%) and
uronic acid (16%). A study by Silva et al. (2009) demon-
strated that the biofilm matrices of C. glabrata had higher
concentrations of proteins and carbohydrates when com-
pared with other species (C. tropicalis and Candida
parapsilosis). On the other hand, antifungal drugs may bind
to beta-glucans, which are constituents of the extracellular
matrix of Candida biofilms, preventing the drug from
reaching its target (Vediyappan et al. 2010). Thus, strate-
gies that focus on eradication of matrix components may
contribute to the control of infections related to biofilms.
Currently, nanotherapeutics have been used to control
biofilm formation through the incorporation of nanopar-
ticles into several materials (Monteiro et al. 2009, 2012a;
Allaker 2010; Cheng et al. 2012; Wady et al. 2012). In
this context, silver nanoparticles (SN) were reported as
antimicrobial agents against bacteria (Sondi and Sondi
2004) and fungi (Kim et al. 2009; Panacek et al. 2009),
and their mechanism of action is multifactorial. These
nanoparticles preferably bind to sulphur-containing pro-
teins, thereby forming pores in the cell wall and mem-
branes and leading to loss of intracellular contents.
Furthermore, nanoparticles attack respiratory chain
enzymes, causing cell disintegration, and interact with
phosphate in the DNA, preventing cell division
(Monteiro et al. 2009; Rai et al. 2009).
According to literature data, SN were able to prevent
biofilm formation by Pseudomonas aeruginosa and Staph-
ylococcus epidermidis (Kalishwaralal et al. 2010). These
nanoparticles were more effective in reducing biofilm
biomass and number of colony forming units (CFU)
when applied to adhered cells than to mature Candida
biofilms (Monteiro et al. 2011). Moreover, the size of SN
and the type of stabilizing agent were not crucial to their
efficacy against C. albicans and C. glabrata biofilms
(Monteiro et al. 2012b). Although the effect of SN on
Candida biofilm biomass and on the number of CFUs
has been reported, there are no studies on the effect of
these nanoparticles in the matrix composition and struc-
ture of Candida biofilms. Therefore, the main aim of this
study was to evaluate the effect of different SN concentra-
tions on the matrix composition (protein, carbohydrate
and DNA content) and the structure (using Scanning
Electron Microscopy (SEM) and Epifluorescence Micros-
copy) of C. albicans and C. glabrata biofilms.
Materials and methods
Preparation of silver colloidal nanoparticles
For the preparation of silver colloidal nanoparticles, all
chemicals were obtained from Merck KGaA, Darmstadt,
Hesse, Germany. These nanoparticles were synthesized by
a process that involves reduction of silver nitrate
(AgNO3) with sodium citrate (Na3C6H5O7) and their sta-
bilization with ammonia (NH3), as evidenced earlier
(Gorup et al. 2011; Monteiro et al. 2011, 2012a,b).
Briefly, a solution of AgNO3 (50 9 103 mol l1) in
deionized water was brought to boiling and an aqueous
solution of Na3C6H5O7 was added to the AgNO3 solu-
tion. The solution turned yellow and a colloidal suspen-
sion was formed. Next, the silver colloids were stabilized
by adding of 75 ml of an ammonia solution
(14 mol l1). The silver colloidal nanoparticles suspen-
sions were characterized as detailed in our previous stud-
ies (Gorup et al. 2011; Monteiro et al. 2011, 2012a,b),
and SN having an average particle size of 5 nm were
used.
Microorganisms and preparation of Candida cell
suspension
The composition (per 1 l of deionized water) of artificial
saliva medium (Lamfon et al. 2003) used in this study
was as follows: 2 g of yeast extract (Liofilchem, Roseto
degli Abruzzi, Italy), 5 g of peptone (Liofilchem), 2 g of
glucose (AppliChem, Darmstadt, Germany), 1 g of mucin
(Sigma-Aldrich, St Louis, MO, USA), 035 g of NaCl
(AppliChem), 02 g of CaCl2 (Riedel-de Ha€en, Seelze,
Germany) and 02 g of KCl (Pronalab, Lisbon, Portugal).
The pH was adjusted to 68.
An oral clinical isolate (324LA/94) of C. albicans, pro-
vided by the culture collection of Cardiff Dental School,
Cardiff, UK, and an oral clinical isolate (D1) of C. glab-
rata, obtained from the biofilm group of the Centre of
Biological Engineering, University of Minho, Braga,
Portugal, were used in all of the experiments. All Candida
strains were stored as frozen stocks with 20% glycerol at
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80°C until required. To prepare the Candida cell
suspension for biofilm growth, clinical isolates were sub-
cultured on Sabouraud dextrose agar (SDA, Liofilchem)
plates for 24 h at 37°C and then, a loopful of the
Candida colonies was transferred into 30 ml of Sabou-
raud dextrose broth (Liofilchem) and incubated overnight
at 37°C in a rotary shaker (at 120 rev min1). After-
wards, Candida cells were harvested by centrifugation
(6500 g for 5 min at 15°C), washed twice with 30 ml of
phosphate buffered saline (PBS; pH 7), enumerated using a
Neubauer chamber and then adjusted to a concentration of
107 cells ml1 in artificial saliva medium. These Candida
cell suspensions were used in the subsequent assays.
Biofilm formation and treatment with silver
nanoparticles
Biofilm formation was performed as described by Silva
et al. (2009). Briefly, 4 ml of standard cell suspensions of
yeasts, prepared as above, were added into each well of a
6-well polystyrene microtitre plate (Orange Scientific,
Braine-l’Alleud, Belgium), and the plate incubated with
shaking (120 rev min1) for 48 h at 37°C. After 24 h, an
aliquot of 2 ml of artificial saliva medium was removed
and an equal volume of fresh artificial saliva was added.
After the incubation period, non-adherent cells were
removed by washing with 4 ml of PBS.
Stock suspensions of silver colloidal nanoparticles were
diluted in Roswell Park Memorial Institute (RPMI) 1640
medium (Sigma-Aldrich) to obtain two different concen-
trations of silver: 54 and 135 lg ml1. These SN concen-
trations were based on a previous study (Monteiro et al.
2011) in which it was verified some effect against
Candida biofilms after exposure to silver concentrations
at or higher than 135 lg ml1. A volume of 4 ml of
each dilution was transferred to the wells of the 6-well
polystyrene microtitre plate, containing pre-formed bio-
films. In control experiments, RPMI 1640 medium with-
out SN was added to the wells. The plates were incubated
at 37°C for 24 h with shaking (120 rev min1). After
treatment with SN, biofilms were washed once with 4 ml
of PBS to remove loosely attached cells.
Biofilm matrix extraction
After treatment with SN, the biofilm matrix was extracted
in accordance with a previously described procedure
(Silva et al. 2009). Biofilms were scraped from the wells
of 6-well microtitre plates using sterilized cell scrapers
(Orange Scientific) and resuspended with PBS. Following,
the biofilm samples were sonicated (Ultrasonic Processor,
Cole-Parmer, IL, USA) for 30 s at 30 W, and the suspen-
sion was vortexed for 2 min. Finally, the suspension was
centrifuged at 3000 g for 10 min at 4°C and the
supernatant filtered through a 045 lm nitrocellulose
filter (Orange Scientific).
Biofilm dry weight determination
For this assay, biofilms removed from the 6-well plates
were filtered on 045 lm sterilized membrane (Pall Corpo-
ration, New York, MI, USA) and dried at 60°C until a con-
stant dry weight. The membrane was also weighed before
biofilm filtering. Thus, biofilm dry weight was obtained as
the difference between the two measurements.
Protein, carbohydrate and DNA quantification
The protein content was determined using the BCA Kit
(Bicinchoninic Acid; Sigma-Aldrich), using bovine serum
albumin (BSA) as the standard (Silva et al. 2009). Briefly,
25 ll of the suspension obtained after biofilm matrix
extraction was transferred into wells of 96-well microtitre
plates containing 200 ll of the mixture of BCA kit
reagents. The plates were incubated at 37°C for 30 min
and the absorbance read in a microtitre plate reader
(Bio-Tek Synergy HT, Izasa, Lisbon, Portugal) at 562 nm.
The total carbohydrate content was measured accord-
ing to the procedure of Dubois et al. (1956), using glu-
cose as a standard. Thus, into a glass tube, 500 ll of the
suspension obtained after biofilm matrix extraction was
mixed with 500 ll of 9% phenol (Panreac, Barcelona,
Spain) and 25 ml of sulfuric acid (95–97%, Applichem).
The solution was homogenized by vortexing, and after
15 min at room temperature, the absorbance was read at
490 nm.
To assess the DNA content in biofilm matrix, a small
volume (15 ll) of the suspension obtained after biofilm
matrix extraction was spectrophotometrically analysed
(at 260 nm and 280 nm) using a Nanodrop Spectropho-
tometer (Nanodrop 1000; Thermo Scientific, Lisbon,
Portugal).
Total proteins, carbohydrates and DNA contents were
expressed as a function of the biofilm dry weight (mg g1
of biofilm dry weight). Three to six separate experiments
were carried out for each condition studied.
Biomass and cultivable cells quantification
Biofilm biomass, obtained after treatment with silver colloi-
dal nanoparticles, was evaluated by the crystal violet (CV)
staining method, as previously described (Silva et al. 2009;
Monteiro et al. 2011). Briefly, biofilms were fixed with 4 ml
of 99% methanol (Romil, Cambridge, UK). After 15 min,
the methanol was removed and the microtitre plates were
allowed to air-dry. Candida biofilms were stained with 4 ml
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of CV stain (1% v/v) (Merck) for 5 min. The plates were
washed with deionized water, allowed to dry at room tem-
perature, and then the CV was removed by adding 4 ml of
acetic acid (33% v/v) (Pronalab) into each well. Afterwards,
200 ll of the solution was transferred to a 96-well
microtitre plate and the absorbance was measured at
570 nm. The experiments were carried out in triplicate and
on three separate occasions.
In addition, biofilms exposed to SN were scraped from
the microtitre plate wells and 100 ll samples were taken
to culturability assessment. Appropriate dilutions of bio-
film cell suspension were plated on SDA, in triplicate.
The SDA plates were incubated at 37°C, and after 24 h,
the number of CFUs per unit area of wells was enumer-
ated. At least three independent assays were performed.
Biofilm structure
Candida biofilm structure was visualized by SEM. First,
Candida biofilms were developed within the 24-well
microtitre plates by dispensing standardized yeasts cell
suspensions (1 ml of a suspension containing 107 cells
ml1 in artificial saliva) into each well and incubated for
48 h at 37°C in a shaker at 120 rev min1. After treat-
ment with different SN concentrations (54 and 135 lg
ml1) for 24 h, the RPMI 1640 medium was aspirated
and each well was rinsed gently with PBS. Subsequently,
samples were dehydrated by washing in a series of etha-
nol (70% for 10 min, 95% for 10 min and 100% for
20 min), and finally air-dried in a desiccator. Afterwards,
samples were mounted onto aluminium stubs, sputter
coated with gold and viewed under a S-360 scanning
electron microscope (Leo, Cambridge, MA, USA).
Biofilm cells structure was also observed by Epifluores-
cence Microscopy. After treatment with SN, biofilm cells
were fixed overnight at room temperature and stained
with Calcofluor (Calcofluor White Stain; Sigma-Aldrich)
(diluted 1 : 100 in ultra pure water) during 15 min. Prior
to the microscopy observation, the cells were thoroughly
washed with deionized water and observed using an Epi-
fluorescence Microscope (BX51; Olympus, Tokyo, Japan)
equipped with a CCD camera (DP71; Olympus) and filter
capable of detecting the yeast cell wall (BP 365–370, FT
400, LP 421).
Statistical analysis
The results of triplicate experiments conducted for each
of the above assays were analysed applying one-way
ANOVA followed by Tukey multiple comparison post hoc
test, using SPSS software (SPSS – Statistical Package for
the Social Sciences, Inc., Chicago, IL, USA). P < 005 was
considered statistically significant.
Results
Protein, carbohydrate and DNA quantification
Table 1 summarizes the results of quantitative analysis of
total proteins, carbohydrates and DNA extracted from
Candida biofilm matrices after treatment with different
SN concentrations. For C. albicans 324LA/94, the protein
content of biofilm matrices was completely unaffected by
SN treatment (P = 0935, ANOVA). On the other hand, the
treatment with 135 and 54 lg SN ml1 for 24 h
increased the total carbohydrate content, but this
increase, when compared with the control group, was
only significant (approx. 71%, P = 0017) for the SN
concentration of 54 lg ml1. There was a significant
reduction in C. albicans 324LA/94 biofilm DNA content
when treated with 135 lg SN ml1 compared to the
control group (approx. 36%, P = 0002). However, there
was no significant difference in the DNA content between
the control group and the biofilm treated with 54 lg
SN ml1.
For C. glabrata D1, the matrix of biofilm treated with
135 lg SN ml1 had a higher amount of proteins and
DNA than the control group (P = 0001; P = 0029) and
the group treated with 54 lg SN ml1 (P < 0001;
P < 0001). It was also observed that the matrix of biofilms
treated with 54 lg SN ml1 contained less total proteins
(approx. 96%, P = 0039) and DNA (approx. 33%,
P = 0009) compared to the control group. In addition,
biofilm matrix of C. glabrata D1 treated with
135 lg SN ml1 contained less total carbohydrates than
the control group. However, interestingly, after treatment
with 54 lg SN ml1 occurred a significant increase regard-
ing the total carbohydrates content compared to the con-
trol group (approx. 158%, P < 0001) and to the group
treated with 135 lg SN ml1 (approx. 270%, P < 0001).
Biomass and cultivable cells quantification
The efficacy of SN colloidal suspensions in reducing total
biomass and the number of CFUs of Candida biofilms
are shown in Fig. 1. According to Fig. 1(a), when com-
pared with the control groups (biofilms without SN),
C. albicans 324LA/94 and C. glabrata D1 achieved biofilm
biomass reductions around 50% (P < 0001) and 47%
(P = 0025) at a silver concentration of 135 lg ml1 and
around 54% (P < 0001) and 90% (P = 0001) at a
concentration of 54 lg ml1, respectively.
With regard to biofilm cultivable cells (Fig. 1b), it was
possible to observe that the treatment (during 24 h) with
SN colloidal suspensions decreased the number of CFUs
for C. albicans 324LA/94; however, only the concentra-
tion of 54 lg ml1 showed a significant statistical
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decrease (reduction of 212log10; P = 0008) when com-
pared with the control group. For C. glabrata D1 bio-
films, the effect of SN was more pronounced, with
decreases of 386log10 (P = 0001) and 646log10
(P < 0001) at silver concentrations of 135 and
54 lg ml1, respectively. Furthermore, for C. glabrata D1
biofilms, the reduction in total biomass (Fig. 1a) and in
the number of CFUs (Fig. 1b) were dependent on silver
concentration and there were statistically significant
differences (P = 0020 and P = 0007, respectively)
between the silver concentrations tested.
Biofilm structure
Biofilm structure was monitored by SEM (Fig. 2). In the
control (Fig. 2ia), C. albicans 324LA/94 biofilm consisted
of a mixture of yeasts and hyphae surrounded by a thick
extracellular matrix. The treatment with 135 lg SN ml1
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Figure 1 Absorbance values per cm2 (a), obtained with crystal violet staining assay, and logarithm of colony forming units per cm2 (b) for Candi-
da albicans 324LA/94 and Candida glabrata D1 biofilms treated with two different silver nanoparticles concentrations. Error bars denote the
standard deviations of the means. *P < 005, as compared to the control groups by using one-way ANOVA with Tukey post hoc test. Silver
concentration (lg ml1): ( ) 0; ( ) 135 and ( ) 54.
Table 1 Mean results and standard deviation for the amounts of each matrix component of Candida biofilms obtained after treatment with two
different silver nanoparticles concentrations
Matrix composition
(mg g1 of biofilm
dry weight)
Candida albicans 324LA/94 Candida glabrata D1
Silver concentration (lg ml1) Silver concentration (lg ml1)
0 135 54 0 135 54
Proteins 2728  634 2737  325 2856  409 867  040 2793  541* 034  002*
Carbohydrates 20233  5205 22264  3024 34677  4750* 23894  7372 16684  4236 61788  3786*
DNA 1502  138 966  038* 1420  101 1007  127 1260  066* 673  054*
*P < 005, as compared to the control group, using one-way ANOVA with Tukey post hoc test.
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(Fig. 2ib) did not have any visible effect on the structure
of C. albicans 324LA/94 biofilm, and similarly to that
observed in Fig. 2(ia), this biofilm synthesized large
amounts of extracellular matrix material and the fungal
cells were almost hidden by the matrix. By contrast, the
treatment of C. albicans 324LA/94 biofilm with
54 lg SN ml1 (Fig. 2ic) resulted in a much less com-
pact biofilm and lower amounts of extracellular poly-
meric material, when compared with the control group.
Interestingly, the structure of C. glabrata D1 biofilms
was affected by SN. In the control group (Fig. 2iia), this
strain revealed a multilayer biofilm composed entirely of
yeasts. However, after treatment with SN in both concen-
trations of 135 (Fig. 2iib) and 54 lg ml1 (Fig. 2iic), the
biofilms displayed a more compact structure than the
control group and having a thinner layer of yeasts cover-
ing the surface. Additionally, it was possible to observe
some clusters of SN (Fig. 2ib,ic,iib,iic) attached to the
Candida biofilms matrices and to the fungal cells.
Epifluorescence microscopy was also used to screen for
structural differences between biofilm cells in the absence
or in the presence of SN. The fluorescent dye Calcofluor
white used in this assay binds to the fungal cell wall allow-
ing its visualization. As observed by SEM, mature Candida
biofilms, under different experimental conditions (without
SN and after treatment with SN) consisted of a network
of cells of all morphologies: yeasts and filamentous forms
(pseudohyphae and hyphae) for C. albicans 324LA/94 bio-
films and only yeasts for C. glabrata D1 biofilms, as
shown in Fig. 3. Moreover, in general, increasing the sil-
ver concentration, the amount of fluorescence and cell
walls stained with Calcofluor white decreased, for both
biofilms (Fig. 3), suggesting that SN induced damage to
cell walls of Candida biofilms.
Discussion
In the study described here, C. glabrata D1 biofilm
matrix treated with SN showed significant modifications
in the protein and DNA contents compared to untreated
biofilm. At a silver concentration of 135 lg ml1, it was
possible to observe statistically significant increases in the
protein and DNA contents of C. glabrata D1 biofilm
matrix, when compared with the control group (Table 1),
probably due to fungal cell lysis and consequent release
of intracellular contents. However, the treatment with the
highest SN concentration (54 lg ml1) showed signifi-
cant reductions in the matrix protein and DNA contents
compared with the control group (Table 1). As silver has
affinity for proteins (Furno et al. 2004) and for phos-
phate groups present in the DNA molecule (Rai et al.
2009), one reason for the results obtained may be the
precipitation of the protein and DNA contents of extra-
cellular matrix during its exposure to SN at high concen-
tration. Thus, SN at 54 lg ml1 were able to promote
cell lysis, release of intracellular constituents, and precipi-
tation of a part of released protein and DNA.
Surprisingly, the phenomena described above were not
observed for C. albicans 324LA/94. The total protein con-
tent of this biofilm matrix was not affected by treatment
with SN. In addition, C. albicans 324LA/94 biofilm
exposed to 135 lg SN ml1 demonstrated a significant
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Figure 2 Scanning electron microscopy images showing the structure of Candida albicans 324LA/94 (i) and Candida glabrata D1 (ii) mature
biofilms (48 h) under different experimental conditions: (a) control group, (b) experimental group (mature biofilms treated during 24 h with silver
nanoparticles at 135 lg ml1) and (c) experimental group (mature biofilms treated with silver nanoparticles at 54 lg ml1). Note agglomerated
silver nanoparticles in an enlarged view of part of biofilms (images ib, ic, iib and iic).
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decrease in DNA content compared to the control, while
the group treated with SN at 54 lg ml1 did not differ
from the control. DNA can be released into extracellular
matrix by dead cells (Mulcahy et al. 2008), from DNA
containing outer membrane vesicles (Schooling and Beve-
ridge 2006), or can be regulated by quorum sensing
(Allesen-Holm et al. 2006). As C. albicans biofilms are
more complex than those of C. glabrata, the results
obtained for protein and DNA contents of C. albicans
324LA/94 biofilm might result from the increased or
decreased expression of genes involved, for example, in
amino acid and phosphate biosyntheses, in response to
SN exposure. In this regard, Vediyappan et al. (2010)
found that C. albicans biofilms exposed to caspofungin
exhibited marked changes in the expression of hypha-spe-
cific genes (such as ALS3 and HWP1), irrespective of the
antifungal concentration used.
The major components of EPS are carbohydrates
(Al-Fattani and Douglas 2006; Paramonova et al. 2009).
Moreover, some studies have shown that the cell wall of
C. albicans is composed by 80 to 90% of carbohydrates,
and the most frequently found are b-glucans (Nett et al.
2007; Paramonova et al. 2009). The fungal cell wall pro-
vides physical strength, limits permeability, and their
components may contribute for resistance to antifungal
agents (de Groot et al. 2008).
In general, after treatment with 54 lg SN ml1, both
C. albicans 324LA/94 and C. glabrata D1 demonstrated
significant increases in total carbohydrate content
compared to the untreated biofilm groups (Table 1).
The increase in carbohydrate content was higher for
C. glabrata D1 biofilm, on which SN were more effective
in reducing total biomass and number of CFUs (Fig. 1).
These results should be seen in conjunction with the epi-
fluorescence microscopy assay, which showed that SN
induced damage to cell walls of both Candida biofilms,
mainly at silver concentration of 54 lg ml1 (Fig. 3ic,
iic). Thus, taken together, these results suggest that the
increases in carbohydrate content can be associated with
changes in cell walls and secretion of their carbohydrates.
Furthermore, it is perhaps not surprising the apparent
increase in the amount of extracellular matrix of C. glab-
rata D1 biofilm, compared to the control group, seen in
Fig. 2(iic). During treatment with SN, in addition to
changes in cell walls, the surviving cells could increase
the production of exopolymeric substances in an attempt
to protect the biofilm, and this fact may have contributed
to the increase in carbohydrate content observed. How-
ever, as the Fig. 2 (ic) shows a apparent decrease in the
amount of EPS, the increase in carbohydrate content for
C. albicans 324LA/94 biofilm treated with SN at
54 lg ml1 (Table 1) may represent only the carbohy-
drates that were released from cell walls affected by SN.
Parallel experiments carried out to examine the effects
of SN on total biomass and number of CFUs (Fig. 1a
and 1b) showed that SN were more effective in eradicat-
ing C. glabrata D1 biofilms, achieving a total biomass
reduction around 90% at a silver concentration of
54 lg ml1, and reductions in the number of biofilm
cells of 386log10 and 646log10 at silver concentra-
tions of 135 and 54 lg ml1, respectively. These findings
confirm those reported in a previous study (Monteiro
50 mµ 50 mµ 50 mµ
50 mµ50 mµ50 mµ
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Figure 3 Epifluorescence microscopy images showing the structure of Candida albicans 324LA/94 (i) and Candida glabrata D1 (ii) mature biofilms
(48 h) under different experimental conditions: (a) control group, (b) experimental group (mature biofilms treated during 24 h with silver nano-
particles at 135 lg ml1) and (c) experimental group (mature biofilms treated with silver nanoparticles at 54 lg ml1).
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et al. 2011), which also revealed the greater susceptibility
of C. glabrata biofilms to SN compared to C. albicans
biofilms. However, the same SN concentrations tested in
the present study (135 and 54 lg ml1) were less effec-
tive against C. albicans and C. glabrata biofilms devel-
oped in the 96-well microtitre plates (Monteiro et al.
2011), especially regarding to total biomass of C. albicans
324LA/94. Probably, the higher shear force acting on the
biofilms formed in 6-well plates, compared with the force
on the biofilms in 96-well plates, may have facilitated the
diffusive transport of SN into and out of the biofilms
(Stewart 2012), contributing to a better antifungal action
of these nanoparticles.
On the other hand, SEM observations described here
(Fig. 2) revealed a trend of SN aggregation, which was
most obvious at the highest silver concentration
(54 lg ml1). These findings are in agreement with those
of Choi et al. (2010), who observed SN aggregation in
the presence of Escherichia coli biofilms, resulting in an
increase of total particle size. It seems reasonable to spec-
ulate that SN might bind to EPS, which have polyanionic
nature (Hoyle et al. 1990), thus accumulating in the bio-
film and retarding their diffusion (Hoyle et al. 1990).
Additionally, these observations support the conclusions
that the original particle size may be a poor exhibit of
true nanoparticle size in biofilms (Monteiro et al. 2012b)
and that the clusters of SN in some regions of Candida
biofilms (Fig. 2) can restrict the antifungal effect of SN
front of an extensive field of action. Possibly, SN agglom-
erated were unable to kill biofilm cells completely because
these particles did not reach their targets.
In summary, it may be concluded that irrespective of
concentration, SN affected the matrix composition of
Candida biofilms assessed in terms of proteins, carbohy-
drates and DNA, except for the protein content of
C. albicans 324LA/94 biofilm, which remained
unchanged. After treatment with SN, SEM observations
revealed structural differences for both biofilms with
regard to spatial arrangement, and it was possible to
observe clusters of SN on the biofilms. Moreover, epiflu-
orescence microscopy images show that SN induced dam-
age to the cell walls of the Candida oral isolates tested,
especially at the highest silver concentration assayed
(54 lg ml1). Finally, a limitation of this study is that
only one strain of each Candida species was evaluated.
Furthermore, future works are needed to fully elucidate
how SN can act within Candida biofilms. Studies on the
cytotoxicity of SN are also necessary for in vivo testing
with such nanoparticles. Researches focusing on these
issues are crucial for the development of alternative ther-
apies that may prevent or control Candida-associated
denture stomatitis and other Candida infections.
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